uniQure (QURE) Acquisitions (2022)
uniQure (QURE) posted quarterly Acquisitions of $1.1 million for Q3 2022, up 31.14% quarter-over-quarter from $822000.0 in Q1 2022.
uniQure (QURE) Acquisitions (2022) Analysis & Trends
uniQure's Acquisitions history runs 1 years deep, the most recent figure standing at $1.1 million for Q3 2022.
- In Q3 2022, Acquisitions changed N/A year-over-year to $1.1 million; the TTM figure through Dec 2022 stood at $1.9 million (changed N/A YoY), while the FY2022 annual figure was $1.9 million, down 96.2% from the prior year.
- Acquisitions for Q3 2022 stood at $1.1 million, up from $822000.0 in the prior quarter.
- The five-year high for Acquisitions was $1.1 million in Q3 2022, with the low at $822000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.08 Mn |
| Mar 31, 2022 | 822,000.00 |